BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23074147)

  • 1. Cytotoxic action of Brazilian propolis in vitro on canine osteosarcoma cells.
    Cinegaglia NC; Bersano PR; Búfalo MC; Sforcin JM
    Phytother Res; 2013 Sep; 27(9):1277-81. PubMed ID: 23074147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer effects of geopropolis produced by stingless bees on canine osteosarcoma cells in vitro.
    Cinegaglia NC; Bersano PR; Araújo MJ; Búfalo MC; Sforcin JM
    Evid Based Complement Alternat Med; 2013; 2013():737386. PubMed ID: 23690851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive effects of antitumor drugs in combination with propolis on canine osteosarcoma cells (spOS-2) and mesenchymal stem cells.
    Bernardino PN; Bersano PRO; Lima Neto JF; Sforcin JM
    Biomed Pharmacother; 2018 Aug; 104():268-274. PubMed ID: 29775894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemical composition and events related to the cytotoxic effects of propolis on osteosarcoma cells: A comparative assessment of Colombian samples.
    Mora DPP; Santiago KB; Conti BJ; de Oliveira Cardoso E; Conte FL; Oliveira LPG; de Assis Golim M; Uribe JFC; Gutiérrez RM; Buitrago MR; Popova M; Trusheva B; Bankova V; García OT; Sforcin JM
    Phytother Res; 2019 Mar; 33(3):591-601. PubMed ID: 30488503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of copper chaperones sensitizes human and canine osteosarcoma cells to carboplatin chemotherapy.
    Inkol JM; Poon AC; Mutsaers AJ
    Vet Comp Oncol; 2020 Dec; 18(4):559-569. PubMed ID: 32060984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMI1 is expressed in canine osteosarcoma and contributes to cell growth and chemotherapy resistance.
    Shahi MH; York D; Gandour-Edwards R; Withers SS; Holt R; Rebhun RB
    PLoS One; 2015; 10(6):e0131006. PubMed ID: 26110620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.
    De Maria R; Miretti S; Iussich S; Olivero M; Morello E; Bertotti A; Christensen JG; Biolatti B; Levine RA; Buracco P; Di Renzo MF
    J Pathol; 2009 Jul; 218(3):399-408. PubMed ID: 19402129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
    McMahon MB; Bear MD; Kulp SK; Pennell ML; London CA
    Am J Vet Res; 2010 Jul; 71(7):799-808. PubMed ID: 20594083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy of canine osteosarcoma with canine bone marrow stem cells, bone morphogenetic protein and carboplatin in an in vivo model.
    Rici REG; Will SEAL; Luna ACL; Melo LF; Santos AC; Rodrigues RF; Leandro RM; Maria DA
    Vet Comp Oncol; 2018 Dec; 16(4):478-488. PubMed ID: 29781255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells.
    Fahey CE; Milner RJ; Kow K; Bacon NJ; Salute ME
    Anticancer Drugs; 2013 Jun; 24(5):519-26. PubMed ID: 23466652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype.
    Jackson M; Serada N; Sheehan M; Srinivasan S; Mason N; Guha M; Avadhani N
    PLoS One; 2018; 13(12):e0209489. PubMed ID: 30576337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory Effects of a Reengineered Anthrax Toxin on Canine and Human Osteosarcoma Cells.
    Mackowiak da Fonseca J; Mackowiak da Fonseca II; Nagamine MK; Massoco CO; Nishiya AT; Ward JM; Liu S; Leppla SH; Bugge TH; Dagli MLZ
    Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32987941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
    Fenger JM; London CA; Kisseberth WC
    ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the bisphosphonate alendronate on viability of canine osteosarcoma cells in vitro.
    Farese JP; Ashton J; Milner R; Ambrose LL; Van Gilder J
    In Vitro Cell Dev Biol Anim; 2004; 40(3-4):113-7. PubMed ID: 15311969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating CXCR4 expression in canine appendicular osteosarcoma.
    Fan TM; Barger AM; Fredrickson RL; Fitzsimmons D; Garrett LD
    J Vet Intern Med; 2008; 22(3):602-8. PubMed ID: 18466248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
    Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
    Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma.
    Morello E; Martano M; Buracco P
    Vet J; 2011 Sep; 189(3):268-77. PubMed ID: 20889358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical and cytotoxic analyses of brown Brazilian propolis (Apis mellifera) and its in vitro activity against itraconazole-resistant Sporothrix brasiliensis.
    Waller SB; Peter CM; Hoffmann JF; Picoli T; Osório LD; Chaves F; Zani JL; de Faria RO; de Mello JR; Meireles MC
    Microb Pathog; 2017 Apr; 105():117-121. PubMed ID: 28219829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo enhancement of canine pulmonary alveolar macrophage cytotoxic activity against canine osteosarcoma cells.
    Kurzman ID; Shi F; Vail DM; MacEwen EG
    Cancer Biother Radiopharm; 1999 Apr; 14(2):121-8. PubMed ID: 10850295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating TrkA expression in canine appendicular osteosarcoma.
    Fan TM; Barger AM; Sprandel IT; Fredrickson RL
    J Vet Intern Med; 2008; 22(5):1181-8. PubMed ID: 18638015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.